Preparation, characterization and investigation of the anti-human ovarian cancer of silver nanoparticles green-formulated by Salvia officinalis leaf aqueous extract
IntroductionIn the present study, we decided to prepare and formulate a new chemotherapeutic drug (silver nanoparticles in aqueous medium using Salvia officinalis leaf aqueous extract) for the treatment of human ovarian cancer in the in vitro condition.Material and methodsThe organometallic chemistry tests such as Scanning Electron Microscopy (SEM), UV–Visible Spectroscopy (UV-Vis), and Fourier Transformed Infrared Spectroscopy (FT‐IR) were used for characterizing of silver nanoparticles. For investigating the antioxidant potentials of AgNO3, Salvia officinalis aqueous extract, and silver nanoparticles, the DPPH test was used in the presence of butylated hydroxytoluene as the positive control. To survey the cytotoxicity and anti-human ovarian cancer activities of AgNO3, Salvia officinalis aqueous extract, and silver nanoparticles, MTT assay was used on the human ovarian cancer cell lines i.e., Caov-3, SK-OV-3, and PA-1. ResultsIn UV-Vis, the clear peak in the wavelength of 421 nm indicated the formation of silver nanoparticles. In FT-IR test, the presence of many antioxidant compounds with related bonds caused the excellent condition for reducing of silver in the silver nanoparticles. The silver nanoparticles inhibited half of the DPPH molecules in the concentration of 251 µg/mL. The best result of anti-human ovarian cancer effects of silver nanoparticles against the above cell lines was observed in the case of the SK-OV-3 cell line. ConclusionsSilver nanoparticles had very low cell viability and anti-human ovarian cancer properties dose-dependently against Caov-3, SK-OV-3, and PA-1 cell lines without any cytotoxicity on the normal cell line (HUVECs).